• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信号转导和转录激活因子3的蛋白抑制剂通过下调活化T细胞核因子c1和破骨细胞相关受体来调节破骨细胞生成。

Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor.

作者信息

Kim Kabsun, Lee Junwon, Kim Jung Ha, Jin Hye Mi, Zhou Bin, Lee Soo Young, Kim Nacksung

机构信息

Research Institute of Medical Sciences and Medical Research Center for Gene Regulation, Chonnam National University Medical School, Hak-Dong 5, Dong-Ku, Gwangju, Korea.

出版信息

J Immunol. 2007 May 1;178(9):5588-94. doi: 10.4049/jimmunol.178.9.5588.

DOI:10.4049/jimmunol.178.9.5588
PMID:17442941
Abstract

Protein inhibitor of activated STAT3 (PIAS3) has been shown to regulate the activity of various transcription factors. In this study, we show that the overexpression of PIAS3 in bone marrow-derived monocyte/macrophage lineage cells attenuates osteoclast formation and down-regulates the expression of NFATc1 and osteoclast-associated receptor (OSCAR), which are important modulators in osteoclastogenesis. PIAS3 has been shown to associate with histone deacetylase 1 as well as with transcription factors, including the microphthalmia transcription factor, NFATc1, and c-Fos. Moreover, overexpression of PIAS3 inhibits the transactivation of target genes such as NFATc1 and OSCAR. This inhibitory effect of PIAS3 is possibly mediated by histone deacetylase 1 recruitment to the promoter regions of NFATc1 and OSCAR. Furthermore, silencing of PIAS3 by RNA interference in osteoclast precursors enhances osteoclast formation as well as gene expression of NFATc1 and OSCAR. Taken together, our results reveal that PIAS3 acts as a modulator in osteoclastogenesis.

摘要

活化STAT3蛋白抑制剂(PIAS3)已被证明可调节多种转录因子的活性。在本研究中,我们发现PIAS3在骨髓来源的单核细胞/巨噬细胞系细胞中的过表达会减弱破骨细胞的形成,并下调NFATc1和破骨细胞相关受体(OSCAR)的表达,而这两者是破骨细胞生成过程中的重要调节因子。PIAS3已被证明可与组蛋白去乙酰化酶1以及转录因子相互作用,这些转录因子包括小眼畸形转录因子、NFATc1和c-Fos。此外,PIAS3的过表达会抑制NFATc1和OSCAR等靶基因的反式激活。PIAS3的这种抑制作用可能是通过组蛋白去乙酰化酶1募集到NFATc1和OSCAR的启动子区域来介导的。此外,通过RNA干扰使破骨细胞前体中的PIAS3沉默会增强破骨细胞的形成以及NFATc1和OSCAR的基因表达。综上所述,我们的结果表明PIAS3在破骨细胞生成过程中起调节作用。

相似文献

1
Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor.信号转导和转录激活因子3的蛋白抑制剂通过下调活化T细胞核因子c1和破骨细胞相关受体来调节破骨细胞生成。
J Immunol. 2007 May 1;178(9):5588-94. doi: 10.4049/jimmunol.178.9.5588.
2
PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.PIAS3在破骨细胞前体细胞中直接负向调节RANKL介导的破骨细胞生成,并通过成骨细胞间接发挥作用。
Blood. 2009 Mar 5;113(10):2202-12. doi: 10.1182/blood-2008-06-162594. Epub 2008 Oct 24.
3
MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR.MHC 类 II 转录激活因子通过下调 NFATc1 和 OSCAR 负调控 RANKL 介导的破骨细胞分化。
Cell Signal. 2010 Sep;22(9):1341-9. doi: 10.1016/j.cellsig.2010.05.001. Epub 2010 May 11.
4
Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.活化T细胞核因子c1在肿瘤坏死因子相关激活诱导细胞因子介导的破骨细胞生成过程中诱导破骨细胞相关受体基因表达。
J Biol Chem. 2005 Oct 21;280(42):35209-16. doi: 10.1074/jbc.M505815200. Epub 2005 Aug 18.
5
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.曲匹地尔,一种血小板衍生生长因子拮抗剂,通过下调 NFATc1 抑制破骨细胞生成,并抑制小鼠的骨丢失。
Biochem Pharmacol. 2013 Sep 15;86(6):782-90. doi: 10.1016/j.bcp.2013.07.015. Epub 2013 Aug 6.
6
Upstream stimulatory factors regulate OSCAR gene expression in RANKL-mediated osteoclast differentiation.上游刺激因子在RANKL介导的破骨细胞分化过程中调节OSCAR基因表达。
J Mol Biol. 2008 Nov 14;383(3):502-11. doi: 10.1016/j.jmb.2008.08.036. Epub 2008 Aug 22.
7
Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.人参皂苷Rb2通过核因子-κB和信号转导及转录激活蛋白3信号通路抑制破骨细胞分化。
Biomed Pharmacother. 2017 Aug;92:927-934. doi: 10.1016/j.biopha.2017.05.115. Epub 2017 Jun 8.
8
Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.人参皂苷 Rh2 通过下调 NF-κB、NFATc1 和 c-Fos 抑制破骨细胞生成。
Bone. 2012 Jun;50(6):1207-13. doi: 10.1016/j.bone.2012.03.022. Epub 2012 Mar 28.
9
ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.ATF3通过与c-Fos和NFATc1蛋白结合来调节破骨细胞分化和活性中的钙信号传导。
Bone. 2017 Feb;95:33-40. doi: 10.1016/j.bone.2016.11.005. Epub 2016 Nov 6.
10
9-Hydroxy-6,7-dimethoxydalbergiquinol inhibits osteoclast differentiation through down-regulation of Akt, c-Fos and NFATc1.9-羟基-6,7-二甲氧基二氢巴马汀通过下调 Akt、c-Fos 和 NFATc1 抑制破骨细胞分化。
Int Immunopharmacol. 2014 May;20(1):213-20. doi: 10.1016/j.intimp.2014.03.001. Epub 2014 Mar 14.

引用本文的文献

1
Exploring the Role of Hormones and Cytokines in Osteoporosis Development.探索激素和细胞因子在骨质疏松症发展中的作用。
Biomedicines. 2024 Aug 12;12(8):1830. doi: 10.3390/biomedicines12081830.
2
Role and Regulation of Transcription Factors in Osteoclastogenesis.转录因子在破骨细胞分化中的作用与调控。
Int J Mol Sci. 2023 Nov 10;24(22):16175. doi: 10.3390/ijms242216175.
3
Comprehensive analysis of epigenetics mechanisms in osteoporosis.骨质疏松症表观遗传机制的综合分析
Front Genet. 2023 Mar 28;14:1153585. doi: 10.3389/fgene.2023.1153585. eCollection 2023.
4
STAT3-mediated osteogenesis and osteoclastogenesis in osteoporosis.STAT3 介导的骨质疏松症中的成骨和破骨作用。
Cell Commun Signal. 2022 Jul 25;20(1):112. doi: 10.1186/s12964-022-00924-1.
5
The Molecular Interaction of Collagen with Cell Receptors for Biological Function.胶原蛋白与细胞受体的分子相互作用及其生物学功能
Polymers (Basel). 2022 Feb 23;14(5):876. doi: 10.3390/polym14050876.
6
Role of OSCAR Signaling in Osteoclastogenesis and Bone Disease.OSCAR信号在破骨细胞生成及骨疾病中的作用
Front Cell Dev Biol. 2021 Apr 12;9:641162. doi: 10.3389/fcell.2021.641162. eCollection 2021.
7
JAK/STAT pathway and molecular mechanism in bone remodeling.骨重塑中的JAK/STAT信号通路及其分子机制
Mol Biol Rep. 2020 Nov;47(11):9087-9096. doi: 10.1007/s11033-020-05910-9. Epub 2020 Oct 24.
8
Epigenetic Regulators Involved in Osteoclast Differentiation.参与破骨细胞分化的表观遗传调节剂。
Int J Mol Sci. 2020 Sep 25;21(19):7080. doi: 10.3390/ijms21197080.
9
Involvement of Noncoding RNAs in the Differentiation of Osteoclasts.非编码RNA在破骨细胞分化中的作用
Stem Cells Int. 2020 Aug 25;2020:4813140. doi: 10.1155/2020/4813140. eCollection 2020.
10
STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription.STAT3 通过调控 NFATc1 转录控制破骨细胞分化和骨稳态。
J Biol Chem. 2019 Oct 18;294(42):15395-15407. doi: 10.1074/jbc.RA119.010139. Epub 2019 Aug 28.